Small cell lung cancer (SCLC) is an aggressive lung tumour strongly associated with
cigarette smoking, with patients often presenting with metastatic disease at the time of …

OBJECTIVE: To assess the role of maintenance or consolidation therapy in the treatment of
small-cell lung cancer (SCLC), a meta-analysis of all published randomized clinical trials …

Objectives Maintenance therapy for patients with advanced non-small-cell lung cancer
(NSCLC) is an increasingly hot topic in the field of clinical NSCLC research. This study …

Abstract Learning Objectives After completing this course, the reader will be able to:
Consider tumor histology when making treatment decisions for patients with NSCLC. Identify …

Although substantial progress has been made in the therapeutic options currently available
for patients with advanced non-small cell lung cancer (NSCLC), the overall survival profile …

Although cisplatin (DDP) has been reported to be a promising antitumor therapy for non‑
small cell lung cancer (NSCLC), the effectiveness of the treatment remains limited due to an …

Background To improve the efficacy of first-line therapy for advanced non-small cell lung
cancer (NSCLC), additional maintenance chemotherapy may be given after initial induction …

在发达及发展中国家, 肺癌仍是癌症死亡的重要原因[1]. 其中, 非小细胞肺癌(non-small cell lung
cancer, NSCLC) 占80%-85%, 并且70% 以上NSCLC 患者临床确诊时处于复发或转移性的 …

Objectives To investigate the outcomes of gemcitabine maintenance monotherapy treatment
for metastatic urothelial cancer. Methods Gemcitabine maintenance monotherapy was used …

INTRODUCTION: Maintenance therapy can delay progression and prolong survival in
metastatic non-small-cell lung cancer (mNSCLC). As treatment for mNSCLC is non-curative …